Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: brca1 Mutation Carrier|brca2 Mutation Carrier|Breast Cancer|Hereditary Breast/Ovarian Cancer (brca1, brca2)
Interventions: DRUG: carboplatin|DRUG: docetaxel
Sponsor: University College London Hospitals